Addus HomeCare Corp. (ADUS) is a publicly traded Healthcare sector company. As of November 3, 2026, ADUS trades at $126.38 with a market cap of $2.35B and a P/E ratio of 26.14. ADUS moved +0.30% today. Year to date, ADUS is +18.59%; over the trailing twelve months it is +6.22%. Its 52-week range spans $87.95 to $127.06. Analyst consensus is buy with an average price target of $124.86. Rallies surfaces ADUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ADUS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $126.38 |
| Market Cap | $2.35B |
| P/E Ratio | 26.14 |
| EPS | $4.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $127.06 |
| 52-Week Low | $87.95 |
| Volume | 375.14K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.15B |
| Net Income | $73.60M |
| Gross Margin | 32.48% |
9 analysts cover ADUS: 0 strong buy, 6 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $124.86.